Implementing successful quality outcome programs in ambulatory care: Key questions and recommendations

Journal of Ambulatory Care Management

Volumn 33, Issue 2, 2010, Pages 117-123

  Shalowitz, Joel I ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Effectiveness; Outcomes; Pay for performance; Quality

Indexed keywords

AMBULATORY CARE; ARTICLE; HEALTH CARE QUALITY; ORGANIZATION AND MANAGEMENT; PROGRAM DEVELOPMENT; REIMBURSEMENT; STANDARD; UNITED STATES;

AMBULATORY CARE; EFFICIENCY, ORGANIZATIONAL; PROGRAM DEVELOPMENT; QUALITY ASSURANCE, HEALTH CARE; REIMBURSEMENT, INCENTIVE; UNITED STATES;

EID: 77949559825     PISSN: 01489917     EISSN: None     Source Type: Journal    
DOI: 10.1097/JAC.0b013e3181d9165f     Document Type: Article

References (20)

1. Agency for Healthcare Research and Quality.(2009). Publication No. 090001. Retrieved February 5, 2010, from www.ahrq.gov/qual/nhqr08/nhqr08.pdf
2. Barraclough, B. (2006). The role of safety and quality councils in improving the quality of healthcare: An Australian Perspective. Healthcare Paper, 6, 24-32.
3. Calvan, B. C. (2009, July. Paperwork adds $9 billion to California annual health spending, study says. Sacramento Bee, 17, 9B.
4. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. (2006). American Journal of Kidney Diseases, 47(Suppl 3), S54-S57; and American Journal of Kidney Diseases erratum (2006), 48(3), 518.
5. Chodak, G. W, & Warren, K. S. (2006). Watchful waiting for prostate cancer: a review article. Prostate Cancer and Prostatic Diseases 9, 25-29.
6. Centers for Medicare & Medicaid Services. (2008). Physician quality reporting initiative 2007, reporting experience. Retrieved February 5, 2010, from http:// www.cms.hhs.gov/PQRI/
7. Doran, T., Fullwood, C., Gravelle, H., Reeves, D., Kontopantelis, E., Hiroeh, U., et al. (2006). Pay-forperformance programs in family practices in the United Kingdom. New England Journal of Medicine, 355(4), 375-384.
8. Gejyo, F., Saito, A., Akizawa, T., Akiba, T., Sakai, T., Suzuki, M. et al. (2004). Japanese society for dialysis therapy guidelines for renal anemia in chronic hemodialysis patients. Therapy Apheresis Dialysis, 8(6), 443-459.
9. Gatti, J. C. (2002). Cochrane for clinicians: putting evidence into practice. American Family Physician, 65(11), 2259.
10. Glendinning, D. (2008, November 17). AMA survey results: Medicare rated as poor performer during debut of pay-for-reporting. AMNews. Retrieved February 5, 2010, from http://www.ama-assn.org.ezproxy.galter. northwestern.edu/amednews/ 2008/11/17/gvl11117. htm
11. Grimshaw, J. M., Shirran, L., Thomas, R., Mowatt, G., Fraser, C., Bero, L., et al. (2001). Changing provider behavior: An overview of systematic reviews of interventions. Source: Medical Care, 39(8, Suppl II), II2-II45.
12. Iezzoni, L. I. (1997). The risks of risk adjustment. Journal of the American Medicine of Association, 278, 1600-1607.
13. Marcus, A. D. (2007, February, 13). Cancer patients gain say in drug approvals FDA and drug makers had reports from trial participants to traditional measures such as survival, tumor shrinkage. The Wall Street Journal, D1.
14. Marshall, M. N., Shekelle, P. G., Leatherman, S., & Brook, R. H. (2000). The public release of performance data. Journal of the American Medicine of Association, 283, 1866-1874.
15. McGlynn, E. A., Asch, S. M., Adams, J., Keesey, J., Hicks, J., DeCristofaro, A., et al. (2003). The quality of health care delivered to adults in the United States. New England Journal of the Medicine, 348(26), 2635-2645.
16. National Institute for Clinical Excellence. (2006). CG: 39 Anæmia Management in Chronic Kidney Disease. Retrieved February 5, 2010, from http://guidance. nice.org.uk/CG39.
17. Nebeker, J. R., Hoffman, J. M.,Weir, C. R., Bennett, C. L., & Hurdle, J. F. (2006). High rates of adverse drug events in a highly computerized hospital. Archives of Internal Medicine, 165, 1111-1116.
18. PriceWaterhouseCoopers. (2007). Keeping Score A comparison of pay-for-performance programs among commercial insurers. Retrieved February 5, 2010, from http://www.pwc.com/us/en/healthcare/ publications/keeping-score.jhtml
19. Shekelle, P. G. (2002). Why don't physicians enthusiastically support quality improvement programmes? Quality and Safety in Health Care, 11, 6.
20. Westphal, S. P. (2006, October, 24). Drug-coated stents show use risk; study says devices by J&J, Boston scientific present a higher danger of clots. Wall Street Journal, A.12.